News
Axela acquires Xceed Molecular
July 27, 2010 8:34 am | by Mass High Tech: The Journal of New England Technology | CommentsXceed Molecular, based in Toronto and Wellesley, has been acquired by Anaheim, Calif., based Axela Inc. which plans to provide clinical researchers with a suite of products for enhanced analysis of proteins, pathogens, DNA and RNA.
BD Board of Directors Elects Christopher Jones
July 27, 2010 8:34 am | by Becton, Dickinson and Company | Comments(July 26, 2010) -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, announced today that it has elected Christopher Jones to its Board of Directors, effective today. Mr. Jones, 55, is the former Chief Executive Of
Mindray to Attend the 2010 American Association for Clinical Chemistry Conference
July 27, 2010 8:34 am | by Bio-Medicine.Org | CommentsSHENZHEN, China , July 27 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR ), a leading developer, manufacturer and marketer of medical devices worldwide, today announced it will attend the 2010 American Association for Clinical Chemistry (AACC) conference in...
Moffitt Cancer Center and CvergenX, Inc. Sign Licensing Agreement
July 27, 2010 8:33 am | by Bio-Medicine.Org | CommentsTAMPA, Fla. , July 27 /- Moffitt Cancer Center and CvergenX, Inc. , announced today that they have entered into a licensing agreement under which CvergenX has acquired the exclusive worldwide rights to a technology platform that individualizes radiation therapy, InterveneXRT™....
O.I. Corporation Announces Third Quarter Dividend
July 27, 2010 7:45 am | by The Associated Press | CommentsO.I. Corporation (NASDAQ: OICO) today announced that its Board of Directors declared a quarterly cash dividend of $0.05 per common share payable on August 30, 2010 to shareholders of record at the close of business on August 13, 2010.About O.I. Corporation:O.I. Corporation, dba OI Analytical,...
Covidien closes $250M tender offer for Somanetics
July 27, 2010 7:38 am | by Mass High Tech: The Journal of New England Technology | CommentsCovidien plc reports it has completed its tender offer through a subsidiary, Covidien DE Corp., to purchase all of the outstanding common shares of Somanetics Corp. of Michigan in a deal that would be worth about $250 million.
Joint Statement on Wireless Medical Devices - U.S. Food and Drug Administration, Federal Communications Commission
July 27, 2010 7:30 am | by U.S. Food & Drug Administration | CommentsInnovation in broadband and wireless-enabled medical devices holds significant promise for enhancing health and reducing the costs of health care for all Americans. Examples include wireless sensors that remotely monitor heart rhythm and portable...
Health Robotics Surpasses 100 Installations Milestone and Acquires Two I.V. Room of the Future Partner Companies
July 27, 2010 6:32 am | by Bio-Medicine.Org | CommentsBOZEN, SUD-TIROL, Italy , July 27, 2010 /- Health Robotics announced that it has reached final agreements to acquire all assets from Italy -based MEDarchiver S.r.l. and Biomedical Technology Consulting S.r.l., merging these companies' employees and operations, re-entering direct sales...
Cynosure revenue is up, losses down
July 27, 2010 5:34 am | by Mass High Tech: The Journal of New England Technology | CommentsWestford-based Cynosure Inc., a maker of lasers used for cosmetic procedures and dermatology-related applications, reported a modest growth in second quarter revenue, but a significant cut in Q2 losses compared to 2009.
HealthSouth investors to get settlement cash
July 27, 2010 4:45 am | by The Associated Press | CommentsThe Securities and Exchange Commission says $106 million that HealthSouth Corp. agreed to pay investors is ready for distribution to those who qualify.The payout stems from of an SEC lawsuit in 2003. Birmingham-based hospital operator HealthSouth agreed to settle the suit in 2005 by paying $100...
Omeros Enrolls First Patient in Phase 2b Clinical Trial Evaluating OMS302 in Patients Undergoing Cataract Surgery
July 27, 2010 4:35 am | by Bio-Medicine.Org | CommentsSEATTLE , July 27 /- Omeros Corporation (Nasdaq: OMER ), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced that it has enrolled the first patient in its Phase...
BioElectronics and YesDTC Holdings Receive Japanese Regulatory Review Date
July 27, 2010 4:35 am | by Bio-Medicine.Org | CommentsFREDERICK, Md. , July 27 /- BioElectronics Corp. (Pink Sheets: BIEL), manufacturers of innovative pain relieving medical devices, today announced its distribution partner for Japan , YesDTC Holdings, Inc. (OTC Bulletin Board: YESD) has received notification from its legal staff of the...
YesDTC Holdings and BioElectronics Receive Japanese Regulatory Review Date
July 27, 2010 4:35 am | by Bio-Medicine.Org | CommentsSAN FRANCISCO , July 27 /- YesDTC Holdings, Inc. (OTC Bulletin Board: YESD), a direct-to-consumer marketer and global distributor of consumer goods and products and BioElectronics Corp. (Pink Sheets: BIEL), manufacturers of innovative pain relieving medical devices, today announced the...
Thoratec Announces Termination of Proposed Sale of ITC
July 27, 2010 4:34 am | by Bio-Medicine.Org | CommentsPLEASANTON, Calif. , July 27 /- Thoratec Corporation (Nasdaq: THOR ), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, announced today the termination, by mutual agreement, of the previously announced agreement to sell...
Sysmex America to Launch Complete Cell Image Analysis Portfolio at AACC
July 27, 2010 4:34 am | by Bio-Medicine.Org | CommentsMUNDELEIN, Ill. , July 27 /- Sysmex America, Inc., a leading medical diagnostic instrument manufacturer and information systems developer, today announced plans to debut its expanded cell image analysis portfolio during this year's American Association of Clinical Chemistry's (AACC)...
